510(k) Report

510(k) · Cleared

Recalled · 2007

Axsym Gentamicin

K935376510(k) TraditionalCleared Jun 21, 1994225-day reviewClass II21 CFR 862.3450Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Mfg., Inc. · LCD Enzyme Immunoassay, Gentamicin

Cleared on Jun 21, 1994 after a 225-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 3 later devices descend from it. It has been recalled once.

Decided
Jun 21, 1994
Review
225 days
Class
Class II
Product code
LCD
Recalls
1
Predicates
0

3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2011: 1 descendant cleared2001: 1 descendant cleared2025: 1 descendant cleared1990200020102020
  1. This deviceK935376 Axsym GentamicinAbbott Mfg., Inc. · 1994
  2. Descendant · cites it directly · 1 of its ownK102699 Architect Igentamicin Reagents; Architect Igentamicin CalibratorsAbbott Laboratories · 2011 · Recalled
  3. Descendant · 2 generations on · 0 of its ownK243500 ARCHITECT iGentamicinAbbott Laboratories · 2025
  4. Descendant · cites it directly · 0 of its ownK012311 Immulite 2000 Gentamicin, Models L2KGE2 (200 Tests), L2KGE6 (600…Diagnostic Products Corp. · 2001

Most influential descendants

Showing 3 of 3 · See all
  • K102699Architect Igentamicin Reagents; Architect Igentamicin CalibratorsAbbott Laboratories · 2011 · cites it directly1descendant
  • K243500ARCHITECT iGentamicinAbbott Laboratories · 2025 · 2 generations on0descendants
  • K012311Immulite 2000 Gentamicin, Models L2KGE2 (200 Tests), L2KGE6 (600 Tests)Diagnostic Products Corp. · 2001 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K935376Axsym GentamicinAbbott Mfg., Inc.1994—
+1K102699Architect Igentamicin Reagents; Architect Igentamicin CalibratorsAbbott Laboratories20111
+2K243500ARCHITECT iGentamicinAbbott Laboratories2025—
+1K012311Immulite 2000 Gentamicin, Models L2KGE2 (200 Tests), L2KGE6 (600 Tests)Diagnostic Products Corp.2001—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200110
201110
202510
FIG. 1 — Lineage of K935376, 1994–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LCD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LCD device

  1. #1 K243500 ARCHITECT iGentamicinscore 9.9 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K102699Architect Igentamicin Reagents; Architect Igentamicin CalibratorsAbbott Laboratories20111
K012311Immulite 2000 Gentamicin, Models L2KGE2 (200 Tests), L2KGE6 (600 Tests)Diagnostic Products Corp.20010

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 26, 2007Not classifiedZ-0930-2008OtherIncorrect Results -- Through evaluation of stability, Abbott have found a decrease in the calibrator A to F span with these reagents lots, which may produce the following results: - Printed Error Code "SPAN LESS THAN MIN SPAN" - Controls…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K102699 (Abbott Laboratories, 2011) has gone furthest, with 1 descendant of its own.

How does its category compare?

All LCD devices

LCD Enzyme Immunoassay, Gentamicin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LCD

1in 2025

2011: 12025: 1
2007high 1 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LCD

Too few LCD 510(k)s in any year since 2007 to give a median.

Recalls per year · LCD

1in 2010

2007: 12009: 42010: 1
2007high 4 (2009) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LCD

2in 2024

2009: 32010: 42011: 32012: 192013: 162014: 32015: 22016: 82017: 12018: 22019: 12020: 12024: 2
2007high 19 (2012) · low 0 (2007)2025

MAUDE reports naming product code LCD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20080—00
20090—43
20100—14
20111—03
20120—019
20130—016
20140—03
20150—02
20160—08
20170—01
20180—02
20190—01
20200—01
20210—00
20220—00
20230—00
20240—02
20251—00
20260—0—
Cite this page

510(k) Report. “K935376: Axsym Gentamicin.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K935376

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026